Emily Day

612 total citations
28 papers, 348 citations indexed

About

Emily Day is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Emily Day has authored 28 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Surgery. Recurrent topics in Emily Day's work include Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (8 papers) and Ovarian cancer diagnosis and treatment (3 papers). Emily Day is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (11 papers), Prostate Cancer Treatment and Research (8 papers) and Ovarian cancer diagnosis and treatment (3 papers). Emily Day collaborates with scholars based in United Kingdom, Spain and Canada. Emily Day's co-authors include Curtis Offiah, Francesca Fiorentino, Hashim U. Ahmed, Mathias Winkler, A Toby Prevost, David Eldred‐Evans, Martin J. Connor, Henry Tam, Heminder Sokhi and Anwar R. Padhani and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Journal of Clinical Epidemiology.

In The Last Decade

Emily Day

24 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily Day United Kingdom	10	150	100	45	43	40	28	348
Gordon Wright Australia	4	197 1.3×	69 0.7×	29 0.6×	22 0.5×	91 2.3×	4	328
Najla Aldaoud Jordan	7	261 1.7×	91 0.9×	16 0.4×	22 0.5×	78 1.9×	23	388
Raghu Rajan Canada	10	104 0.7×	101 1.0×	24 0.5×	32 0.7×	94 2.4×	21	375
Joshua A. Halpern United States	10	170 1.1×	109 1.1×	30 0.7×	10 0.2×	62 1.6×	18	397
Lluís Fumadó Spain	12	228 1.5×	47 0.5×	23 0.5×	16 0.4×	43 1.1×	38	341
P. Cathcart United Kingdom	9	241 1.6×	167 1.7×	45 1.0×	17 0.4×	235 5.9×	34	613
Sennett K. Kim United States	8	343 2.3×	66 0.7×	78 1.7×	10 0.2×	79 2.0×	13	499
Rikiya Taoka Japan	13	256 1.7×	182 1.8×	39 0.9×	22 0.5×	89 2.2×	64	557
Jaime O. Herrera‐Cáceres Canada	10	182 1.2×	127 1.3×	28 0.6×	12 0.3×	103 2.6×	52	431
Yanxiang Shao China	12	124 0.8×	119 1.2×	30 0.7×	8 0.2×	102 2.5×	32	356

Countries citing papers authored by Emily Day

Since Specialization

Citations

This map shows the geographic impact of Emily Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Day more than expected).

Fields of papers citing papers by Emily Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Day. The network helps show where Emily Day may publish in the future.

Co-authorship network of co-authors of Emily Day

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Day. A scholar is included among the top collaborators of Emily Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Day. Emily Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marth, Christian, Tjoung‐Won Park‐Simon, Carol Aghajanian, et al.. (2023). #1120 Durvalumab with paclitaxel/carboplatin + bevacizumab then maintenance durvalumab, bevacizumab + olaparib in patients with newly diagnosed advanced ovarian cancer without a tumour BRCA1/2 mutation: results from the DUO-O/ENGOT-Ov46/AGO-OVAR 23/GOG-3025 trial. VBN Forskningsportal (Aalborg Universitet). A428.3–A429. 2 indexed citations

Eldred‐Evans, David, Henry Tam, Heminder Sokhi, et al.. (2023). An Evaluation of Screening Pathways Using a Combination of Magnetic Resonance Imaging and Prostate-specific Antigen: Results from the IP1-PROSTAGRAM Study. European Urology Oncology. 6(3). 295–302. 15 indexed citations

Reddy, Deepika, Tim Dudderidge, Stuart McCracken, et al.. (2023). LBA03-07 IMPERIAL PROSTATE-4 COMPARATIVE HEALTHCARE RESEARCH OUTCOMES OF NOVEL SURGERY IN PROSTATE CANCER (IP4-CHRONOS): EARLY FEASIBILITY, SAFETY AND FUNCTIONAL OUTCOMES FROM A PILOT RCT. The Journal of Urology. 209(Supplement 4).

Eldred‐Evans, David, Mathias Winkler, Martin J. Connor, et al.. (2023). Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study. Prostate Cancer and Prostatic Diseases. 26(3). 531–537.

Fiorentino, Francesca, Consuelo Rosa, & Emily Day. (2022). Statistical methods for handling compliance in randomized controlled trials of device interventions: a systematic review. Journal of Clinical Epidemiology. 152. 226–237.

Eldred‐Evans, David, Henry Tam, Heminder Sokhi, et al.. (2022). Direct mail from primary care and targeted recruitment strategies achieved a representative uptake of prostate cancer screening. Journal of Clinical Epidemiology. 149. 98–109. 3 indexed citations

Rosa, Consuelo, et al.. (2022). Statistical analysis plan for the Dual mTorc Inhibition in advanCed/recurrent Epithelial ovarian, fallopian tube or primary peritoneal cancer (of clear cell, endometrioid and high-grade serous type, and carcinosarcoma) trial (DICE). Trials. 23(1). 13–13. 3 indexed citations

Day, Emily, David Eldred‐Evans, A Toby Prevost, Hashim U. Ahmed, & Francesca Fiorentino. (2022). Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM study. BMC Medical Research Methodology. 22(1). 70–70. 6 indexed citations

Hughes, Alex, et al.. (2022). Global value chains for medical gloves during the COVID‐19 pandemic: Confronting forced labour through public procurement and crisis. Global Networks. 23(1). 132–149. 18 indexed citations

10.

Reddy, Deepika, Tim Dudderidge, Taimur T. Shah, et al.. (2022). Comparative healthcare research outcomes of novel Surgery in prostate cancer (IP4-CHRONOS): Pilot RCT assessing feasibility of randomization for focal therapy in localized prostate cancer.. Journal of Clinical Oncology. 40(16_suppl). 5086–5086. 4 indexed citations

11.

Bass, Edward, Thiagarajah Sasikaran, Emily Day, et al.. (2021). PROState Pathway Embedded Comparative Trial: The IP3-PROSPECT study. Contemporary Clinical Trials. 107. 106485–106485. 2 indexed citations

12.

Day, Emily, A Toby Prevost, Matthew R. Sydes, et al.. (2021). Feasibility of Comparative Health Research Outcome of Novel Surgery in prostate cancer (IP4-CHRONOS): statistical analysis plan for the randomised feasibility phase of the CHRONOS study. Trials. 22(1). 547–547. 2 indexed citations

13.

Vergis, Nikhil, Vaibhav B. Patel, Justyna Czyzewska-Khan, et al.. (2021). IL-1 Signal Inhibition In Alcoholic Hepatitis (ISAIAH): a study protocol for a multicentre, randomised, placebo-controlled trial to explore the potential benefits of canakinumab in the treatment of alcoholic hepatitis. Trials. 22(1). 792–792. 17 indexed citations

14.

Molinero, Ana, Eva Calvo, Thomas Beaney, et al.. (2021). May Measurement Month 2019: an analysis of blood pressure screening results from Spain. European Heart Journal Supplements. 23(Supplement_B). B138–B140. 6 indexed citations

15.

Houéhanou, Corine, et al.. (2021). May Measurement Month 2019: an analysis of blood pressure screening results from Benin–Sub-Saharan Africa. European Heart Journal Supplements. 23(Supplement_B). B24–B26. 1 indexed citations

16.

Reddy, Deepika, Taimur T. Shah, Tim Dudderidge, et al.. (2020). Comparative Healthcare Research Outcomes of Novel Surgery in prostate cancer (IP4-CHRONOS): A prospective, multi-centre therapeutic phase II parallel Randomised Control Trial. Contemporary Clinical Trials. 93. 105999–105999. 17 indexed citations

17.

Connor, Martin J., Taimur T. Shah, Olivia Naismith, et al.. (2020). Initial experience of the adjuvant treatments to the local tumor for metastatic prostate cancer: Assessment of novel treatment algorithms, a multicenter, phase II randomized controlled trial (IP2-ATLANTA).. Journal of Clinical Oncology. 38(15_suppl). TPS5600–TPS5600.

18.

Offiah, Curtis & Emily Day. (2016). The craniocervical junction: embryology, anatomy, biomechanics and imaging in blunt trauma. Insights into Imaging. 8(1). 29–47. 70 indexed citations

19.

Day, Emily, et al.. (1968). Auscultation of Foetal Heart Rate: an Assessment of its Error and Significance. BMJ. 4(5628). 422–424. 19 indexed citations

20.

Day, Emily, et al.. (1956). Fibrinolytic Activity in Human Prostatic Fluid and Semen. Fertility and Sterility. 7(1). 80–87. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact